North Wales, PA, United States of America

Niranjan Y Sardesai

This inventor holds 30 USPTO granted patents and 17 published patent applications, plus 12 CIPO patents and 12 EPO patents, primarily in Vaccine Development. Top assignees: Inovio Pharmaceuticals, Inc., University of Pennsylvania, Vgx Pharmaceuticals, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niranjan Y Sardesai. Retrieved from https://idiyas.com/inventor/niranjan-y-sardesai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 17)

% Patents Active = 90.0

CIPO Patents = 12 (Patent Applications = 12)

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 150(Granted Patents)

Location History:

North Wales, PA (US) (2010 - 2016)
Blue Bell, PA (US) (2014 - 2024)

Company Filing History:

23 out of 93

Inovio Pharmaceuticals, Inc.

patents

23 out of 2,659

University of Pennsylvania

patents

3 out of 18

Vgx Pharmaceuticals, Inc.

patents

4. 2 out of 245

Mesoscale Technologies, LLC.

The Trustees of the Universtiy of Pennsylvania

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

FMDV

Prostate Antigens

MERS-CoV

DNA Antibodies

Immunotherapy

Dengue Virus

Synthetic Antibody

Clostridium Difficile

Checkpoint Inhibitors

Malaria Vaccines

Arenavirus Vaccines

Flavivirus

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049479 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2024-07-30),

2. 11980659 - Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same (2024-05-14),

3. 11896654 - DNA monoclonal antibodies targeting checkpoint molecules (2024-02-13),

4. 11801298 - MERS-CoV vaccine (2023-10-31),

5. 11278619 - DNA antibody constructs and method of using same (2022-03-22),

6. 11208470 - DNA antibody constructs and method of using same (2021-12-28),

7. 11135284 - MERS-CoV vaccine (2021-10-05),

8. 11124545 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2021-09-21),

9. 11116838 - Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy (2021-09-14),

10. 11045535 - Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same (2021-06-29),

11. 10835595 - PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy (2020-11-17),

12. 10799572 - Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria (2020-10-13),

13. 10548971 - MERS-CoV vaccine (2020-02-04),

14. 10294278 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2019-05-21),

15. 10087240 - DNA antibody constructs and method of using same (2018-10-02),

Title: Niranjan Y Sardesai: Pioneering Inventor from North Wales, PA

Introduction: Niranjan Y Sardesai is a highly accomplished inventor based in North Wales, PA, known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Sardesai holds several patents in the areas of gene therapy, mRNA technology, and drug delivery systems, with his most recent patent focusing on a novel method for targeted cancer treatment.

Career Highlights: With over two decades of experience in the industry, Sardesai has worked with leading biotech companies and research institutions to develop innovative solutions for complex medical challenges. His work has been instrumental in advancing the field of personalized medicine.

Collaborations: Throughout his career, Sardesai has collaborated with top scientists, researchers, and medical professionals to bring cutting-edge technologies from the lab to the market. His collaborative approach has led to several successful partnerships and groundbreaking discoveries.

Conclusion: Niranjan Y Sardesai's passion for innovation and commitment to improving patient outcomes have established him as a key figure in the biotech industry. His pioneering work continues to inspire the next generation of inventors and researchers in the field.

Profile summary based on public USPTO records.